Therapeutics
All prediction markets related to Therapeutics
Markets
36
Active
15
Total Volume
$2.0M
Resolved
Will CRISPR Therapeutics (CRSP) beat quarterly earnings?
$7K volume
0.0%
Will CRISPR Therapeutics (CRSP) beat quarterly earnings?
$357 volume
69.0%
Resolved
Will CRISPR Therapeutics (CRSP) beat quarterly earnings?
$12K volume
100.0%
Resolved
Will Johnson & Johnson say "Halda Therapeutics" or "Haida Therapeutics" during earnings call?
$4K volume
100.0%
FDA approves Axsome Therapeutics' AXS-05?
$3K volume
100.0%
Resolved
FDA approves Capricor Therapeutics’ Deramiocel for Duchenne muscular dystrophy by August 31?
$11K volume
0.0%
FDA approves Grace Therapeutics’ GTx-104?
$1K volume
83.0%
Resolved
FDA approves LENZ Therapeutics’ LNZ100 for presbyopia by August 31?
$7K volume
100.0%
Resolved
FDA approves Outlook Therapeutics’ ONS-5010 for wet AMD?
$4K volume
0.0%
Resolved
FDA approves PTC Therapeutics’ Vatiquinone for Friedreich’s ataxia?
$2K volume
0.0%
Resolved
Will Nurix Therapeutics (NRIX) beat quarterly earnings?
$5K volume
0.0%
Resolved
Will Agomab Therapeutics NV not IPO before April 2026?
$1K volume
0.0%
Resolved
Will Agomab Therapeutics NV's market cap be between $600M and $700M at market close on IPO day?
$107K volume
0.0%
Resolved
Will Agomab Therapeutics NV's market cap be between $700M and $800M at market close on IPO day?
$8K volume
100.0%
Resolved
Will Agomab Therapeutics NV's market cap be between $800M and $900M at market close on IPO day?
$20K volume
0.0%
Resolved
Will Agomab Therapeutics NV's market cap be between $900M and $1.0B at market close on IPO day?
$1K volume
0.0%
Resolved
Will Agomab Therapeutics NV's market cap be greater than $1.0B at market close on IPO day?
$2K volume
0.0%
Resolved
Will Agomab Therapeutics NV's market cap be less than $600M at market close on IPO day?
$1K volume
0.0%
technology
Will Kailera Therapeutics not IPO before June 2026?
$111 volume
5.5%
technology
Will Kailera Therapeutics’s market cap be between $1.7B and $1.8B at market close on IPO day?
$97 volume
3.5%
technology
Will Kailera Therapeutics’s market cap be between $1.8B and $1.9B at market close on IPO day?
$82 volume
21.5%
technology
Will Kailera Therapeutics’s market cap be between $1.9B and $2.0B at market close on IPO day?
$81 volume
14.5%
technology
Will Kailera Therapeutics’s market cap be between $2.0B and $2.1B at market close on IPO day?
$77 volume
17.5%
technology
Will Kailera Therapeutics’s market cap be greater than $2.1B at market close on IPO day?
$1K volume
53.5%
technology
Will Kailera Therapeutics’s market cap be less than $1.7B at market close on IPO day?
$144 volume
6.5%
Resolved
Will MapLight not IPO by December 31, 2025?
$3K volume
0.0%
Resolved
Will MapLight Therapeutics Inc IPO closing market capitalization be above 1.3 billion?
$161 volume
0.0%
Resolved
Will MapLight Therapeutics Inc IPO closing market capitalization be below 700 million?
$11K volume
0.0%
Resolved
Will MapLight Therapeutics Inc IPO closing market capitalization be between 1 billion and 1.3 billion?
$2K volume
0.0%
Resolved
Will MapLight Therapeutics Inc IPO closing market capitalization be between 700 million and 1 billion?
$32K volume
100.0%
Will Odyssey Therapeutics' market cap be at least $1.4B at market close on IPO day?
$4K volume
0.1%
Will Odyssey Therapeutics' market cap be between $0.8B and $1.1B at market close on IPO day?
$7K volume
0.1%
Will Odyssey Therapeutics' market cap be between $1.1B and $1.4B at market close on IPO day?
$4K volume
0.1%
Will Odyssey Therapeutics' market cap be less than $0.8B at market close on IPO day?
$6K volume
100.0%
Resolved
Will Odyssey Therapeutics not IPO before July 2026?
$2K volume
0.0%
Will Viking Therapeutics be acquired before 2027?
$1.7M volume
45.5%